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Science and Technology, Daejeon, KoreaABSTRACT The propensity of a-synuclein to form amyloid plays an important role in Parkinson’s disease. Three familial muta-
tions, A30P, E46K, and A53T, correlate with Parkinson’s disease. Therefore, unraveling the structural effects of these mutations
has basic implications in understanding the molecular basis of the disease. Here, we address this issue through comparing
details of the hydration of wild-type a-synuclein and its A53T mutant by a combination of wide-line NMR, differential scanning
calorimetry, and molecular dynamics simulations. All three approaches suggest a hydrate shell compatible with a largely disor-
dered state of both proteins. Its fine details, however, are different, with the mutant displaying a somewhat higher level of hydra-
tion, suggesting a bias to more open structures, favorable for protein-protein interactions leading to amyloid formation. These
differences disappear in the amyloid state, suggesting basically the same surface topology, irrespective of the initial monomeric
state.INTRODUCTIONParkinson’s disease (PD)—like Alzheimer’s disease (AD)—
is a lingering neurodegenerative disease that induces degen-
eration of substantia nigra in the brain in people typically
older than age 60. The loss of dopaminergic neurons causes
movement disorders; common symptoms are tremor, ri-
gidity, bradykinesia, and balance problems. PD is character-
ized by the presence of cytoplasmic neuronal deposits,
so-called Lewy bodies (LBs) (1). The major component of
LBs is a-synuclein, which forms ordered amyloid fibrils:
in fact, a-synuclein immunoreactivity in LBs (2) is the path-
ological hallmark of PD (3). Besides wild-type protein,
a-synuclein also has several inherited, familial mutations
associated with PD, such as A53T (4), A30P (4,5), and
E46K (6).
a-synuclein is a small, highly soluble, heat-stable protein
(7,8) expressed at high levels in the brain, where its normal
function is not fully understood (9–11). This 140-amino
acid protein consists of three regions, 1), an amphipathic
N-terminal region (residues 1–60), 2), the so-called NAC
region (residues 61–95), and 3), the C-terminal region en-
riched in proline and acidic amino acids (residues 96–140).
a-synuclein contains seven repeat regions (KTKEGV)
(12), within which all familial mutations are found; A30P
is located between the second and third repeat, A53T is
between the fourth and fifth repeat, and E46K is within the
fourth repeat region. Within the two repeats in the NAC
region, no mutation has been detected to date that we
know of. It was shown previously that mutation of E46 to
alanine or lysine in position 46 and 83 increases the propen-
sity of a-synuclein to polymerize (13) and glutamic acidSubmitted June 8, 2011, and accepted for publication August 24, 2011.
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modulating the assembly of a-synuclein fibrils.
The polymerization of wild-type and mutant a-synuclein
is time- and concentration-dependent (14). The primary
determinant of polymerization is the NAC region, whereas
the two termini modulate filament formation (13). The
wild-type protein and its mutants show different characteris-
tics in many aspects, such as the rate of fibril formation and
morphology (13–20), which underscores that these mutants
are important in the development of PD. In vitro, A53T
forms fibrils the fastest (19), A30P and E46K are somewhat
slower, and wild-type is the slowest of all (13,18,20). The
reasons for these observed differences are not clear, but
they are probably related to the effect of mutations on
both the solution structure of the protein and the interresidue
interactions critical for amyloid formation. The latter is
probably also manifested in distinct fibril morphology;
wild-type fibrils form twisted filaments with a diameter of
10–15 nm, A30P mutants form straight filaments with a
diameter of 11–16 nm, and A53T mutants form larger
twisted filaments with a diameter of 16–19 nm (14). All fila-
ments observed by circular dichroism (CD) and Fourier
transform infrared (FTIR) spectroscopy show an antiparallel
b-sheet character in all cases (16,17).
To elucidate the underlying structural aspects, the struc-
ture of monomeric a-synuclein was analyzed in terms of
both global and local structural behavior. By means of a
variety of techniques, the full-length protein is best de-
scribed as a random coil in solution (8). Its hydrodynamic
behavior has been studied by size-exclusion chroma-
tography: based on an increased retention time, a slight
compaction by E46K mutation was suggested (21). In
small-angle x-ray scattering experiments, no significant
difference in radius of gyration was noted between A30Pdoi: 10.1016/j.bpj.2011.08.052
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using paramagnetic relaxation enhancement, transient long-
range interactions in the a-synuclein ensemble between the
C-terminus and the central region of the protein were
observed (22,23). These results suggest that fibril formation
is inhibited by intramolecular interactions in the native
structure, and that these interactions are greatly destabilized
by A30P and A53T mutations (24), shifting the conforma-
tional ensemble of a-synuclein to a more open state that
prevails under conditions that promote fibril formation (22).
The structure of wild-type and mutant monomeric
a-synuclein at the secondary-structure level was mostly
studied by CD and NMR. NMR spectroscopy has shown
that the amino terminal region prefers a-helical structure
(25), which is strongly stabilized by binding of lipid
micelles (7,26). The C-terminal region shows an unfolded
structure. Observations using CD indicate that the helical
content overall does not change upon mutation, with only
subtle differences apparent between the wild-type and
E46K mutant protein (21). NMR has shown that the local
helical structure is disturbed by the A30P mutation, and
an enhanced local extended structure is seen in the case of
A53T (27). An AFM experiment addressing both global
and local structural characteristics suggested that the
primarily random-coil structure of a-synucelin shows a
tendency toward b-type behavior in only 7% of the cases
in the wild-type protein, but that this tendency increases to
~38% upon A30P mutation (28).
In this article, we present results on the wild-type and
A53T variants and on solutions containing no buffer agent
or added salt. In all, these experiments suggest that familial
mutations cause small but significant local and global
perturbations in the structural ensemble of a-synuclein,
which are probably relevant with respect to their enhanced
amyloidogenic potential. Our study adds a new dimension
to the structural interpretation of amyloid formation by
close inspection of the hydration properties of wild-type
a-synuclein and the A53T mutant using a combination of
wide-line NMR and differential scanning calorimetry
(DSC).MATERIALS AND METHODS
Purification and sample preparation
of recombinant a-synuclein
Expression and purification of recombinant human wild-type and A53T
mutant a-synuclein in a pRK-172-based expression system was performed
as described (29). In sample preparation, the mass of lyophilized protein
(without any further refinement) was measured and an appropriate amount
of water was added to obtain the requested nominal concentrations,
50 mg/ml and 25 mg/ml. In NMR and DSC measurements, double-distilled
water was used as a solvent. Both NMR and DSC measurements were
carried out on three identical samples prepared independently. Amyloid
was prepared by preincubating protein samples at 37C for 24 h. Formation
of amyloid was confirmed by measuring the fluorescence of 5 mM thioflavin
T (ThT) added to an aliquot of the solution.NMR spectrometry
The portion of mobile proton (water) fraction was directly measured by two
1H NMR methods, recording the free induction decay (FID) signal and
Carr-Purcell-Meiboom-Gill (CPMG)-echo trains (in the temperature range
where echoes could be detected at all). In some detail, the following pulse
sequences have been applied for the FID signal (FID(t), i.e., the inversely
Fourier-transformed spectrum (u)) and the echo signals (t), which denote
the time and frequency domains.
Response to the preparation pulse (Px0) is the FID signal. P represents
a 90 pulse length and x0 the phase of that. All the protons in the sample
contribute to the FID signal. The amplitude of this response at time zero
is proportional to M0 ¼ n0B0/T, where Bo is the magnetic induction, T is
the absolute temperature, and n0 refers to the number of nuclear spins
(protons) in the sample. Otherwise, all the following responses are propor-
tional to the number (n0) of the contributing resonant nuclei.
Response to preparation pulses (Px0-t-2Py0-2t-2Py0-2t-2Py0-2t-., t) is
the CPMG series. The only protons that contribute to the response signal are
those for which the residual dipolar field (which is nearly zero because of
the motional narrowing) is smaller than the inhomogeneous contribution
to the line widths. In that case, only the mobile protons are detected. For
details of our method, see studies by Tompa and colleagues (30,31) and
the references therein. The CPMG echo-train also enables measurements
of the spin-spin (transversal) relaxation rate (32).
Determination of the mobile water fraction is based on a comparison of
the signal intensity or echo amplitude extrapolated to t ¼ 0 with the corre-
sponding values measured at a temperature where the whole sample is in the
liquid state. Measurements were started at every temperature only after
thermal equilibrium was established, i.e., when the NMR response became
time-independent, usually after 10 min. The protein solutions showed no
thermal hysteresis or sign of supercooling below the freezing point of
bulk water. The data presented were obtained while samples were heating.
The effect of freezing on protein solutions was controlled by comparing
NMR parameters obtained before and after a freeze-thaw cycle at temper-
atures above 0C. We found that the freeze-thaw cycle caused no observ-
able changes for the samples as far as the measured NMR parameters are
concerned. The temperature was controlled by an open-cycle cryostat
(Oxford Instruments, Oxfordshire, UK) with an uncertainty of smaller
than 51 K. 1H NMR measurements and data acquisition were accom-
plished using an SXP 4-100 NMR pulse spectrometer (Bruker, Billerica,
MA) at a frequency of 82.6 MHz with a stability of better than 5106.
This value represents the stability of the electromagnet, without any drift
during measurements; the stability of frequency in our system is two orders
of magnitude better. The spatial inhomogeneity of the magnetic field was 2
ppm. The data points in the figures are based on spectra recorded by aver-
aging signals to reach a signal/noise ratio of 50. The number of NMR
signals averaged was varied to achieve the desired signal quantity for
each sample and for unfrozen water quantities. For the determination of
the relative number of mobile protons, the sensitivity of the NMR spectrom-
eter upon temperature change was controlled by measuring the length of the
p/2 pulse to obtain reliable nuclear magnetization values (30). The extrap-
olation to zero time was done by fitting a stretched exponential (31). The
hydration values are presented in units of g water/g protein.DSC
Information about the structural and dynamic changes of protein and water
as solvent can be deduced from the amount of heat absorbed or emitted by
a sample subjected to controlled temperature change. Among calorimetric
methods, DSC allows for precise determination of the enthalpy changes
from the recorded temperature difference (31), DT, between the reference
and the sample branches as DH ¼ K R t2t1 DTdt, where K is the calorimeter
constant. For the measurements, a heat-flux-type DSC 2920 cell (TA Instru-
ments, Newcastle, DE) was used (33). The measurements were carried out
at a controlled heating rate of 2 K$min1.Biophysical Journal 101(9) 2260–2266
FIGURE 2 Temperature dependencies of hydration as measured by 1H
NMR for 50 mg$cm3 a-synuclein dissolved in pure water of the wild
and A53T variants. The dotted line is at the hydration level 0.3 g water/g
protein; solid lines are guides to the eye.
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For molecular dynamics (MD) simulations of the hydration shell of
a-synuclein, we used 101 a-synuclein structures determined by a combina-
tion of paramagnetic relaxation enhancement NMR spectroscopy and
ensemble MD simulations (23) as the best structural approximation of the
disordered state of a-synuclein. For comparison, 10 monomeric globular
structures (of which nine—PDB codes 1e20, 1e9h, 1nb0, 1nun, 1p5v,
1pk6, 1usu, 1xgw, and 1z2f—were comparable in size to a-synuclein,
and one—1ndd—was a ubiquitinlike structure) were also selected. If the
PDB structure did not contain hydrogen, the AddH tool of UCSF Chimera
http://www.cgl.ucsf.edu/chimera/ (a visualization system for exploratory
research and analysis (34)) was used to complete the structure. For
modeling of the hydration shell, we used the solvateShell function of the
sleap program (AmberTools 1.4 http://ambermd.org/) with a shell thickness
of 2–8 A˚ (forcefield, leaprc.ff03.r1; water model, TIP3PBOX). After MD
simulation, we used PERL scripts to calculate the number of water mole-
cules in the hydration shell by calculating, for each water molecule, the
distance between the water molecule (oxygen atom) and the nearest heavy
atom of the protein, and determining the number of water molecules within
a given distance range.RESULTS
In the first step, the hydration-versus-temperature curves
for the wild-type and the mutant A53T a-synucleins at
25 mg/ml concentration was measured. The trends of these
curves are very similar, but the hydration of the A53T
variant shows systematically higher values than the wild-
type a-synuclein (Fig. 1). The mobile water phase could
be detected at 36 5 1C as the lowest temperature for
the wild-type solution, and it appears between 43C and
40C for the A53T mutant. The hydration curves are
essentially identical at a higher protein concentration,
50 mg/ml (Fig. 2). At 25 mg/ml, both the wild-type
and the mutant A53T proteins have hydration-versus-
temperature curves similar to that of the intrinsically disor-
dered protein ERD10 (cf. (32,35)) and show striking contrast
to the hydration curves of the globular proteins ubiquitin
and bovine serum albumin (Fig. 3). The disordered tertiaryFIGURE 1 Temperature dependencies of hydration as measured by 1H
NMR for 25 mg$cm3 a-synuclein dissolved in pure water of the wild
and A53T variants. The dotted line is at the hydration level 0.3 g water/g
protein; solid lines are guides to the eye.
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steeper slopes and higher melting temperatures than are
seen in a globular, i.e., ordered structure. The two-times-
higher protein concentration (50 mg/ml vs. 25 mg/ml)
resulted in reduced hydration levels and trends (Fig. 2),
similar to the hydration curves of globular proteins ubiquitin
and bovine serum albumin (Fig. 3). The hydration curves of
the 50 mg/ml samples are almost temperature-independent
up to 10C, and the mobile water phase appears at
~50C (wild-type a-synuclein at 53 5 1C, A53T
mutant between 53C and 48C).
These results raise the question of how the amyloid fibers
behave in this system. The hydration of the amyloid fibrils
shows a thermal trend different from those of both the intrin-
sically disordered and the globular proteins (Fig. 4). The
low-temperature detection limits of the mobile water phases
are as low as in the case of the globular proteins. There are
no temperature-independent regions of hydration. TheFIGURE 3 Comparison of the temperature dependencies of hydration as
measured by 1H NMR of the 25 mg$cm3 a-synuclein dissolved in pure
water (wild and A53T variants) and the globular (ubiquitin and bovine
serum albumin) or intrinsically disordered (ERD10) proteins. The measured
data points are represented by smooth lines for the sake of clarity. The
dotted line is at the hydration level 0.3 g water/g protein.
FIGURE 4 Comparison of the temperature dependencies of hydration as
measured by 1H NMR of a-synuclein and its amyloid dissolved in pure
water (wild–type (upper) and A53T (lower); protein concentration is
25 mg$cm3 in each case). The dotted line is at the hydration level 0.3 g
water/g protein; solid lines serve as guides to the eye.
FIGURE 5 Enthalpy changes for wild-type a-synuclein, its amyloid, and
the globular protein ubiquitin dissolved in pure water.
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studied. The hydration of the a-synuclein molecules is
roughly two times that of the corresponding amyloid fibers
(Fig. 4). At temperatures below 20C, the difference
between the mobile water phases around the amyloid fibrils
and the corresponding a-synuclein molecules is 1.5–2 times
larger for A53T than for the wild-type variant. The enthalpy
changes measured by DSC compared to that of water
(Fig. 5) show marked differences between wild-type
a-synuclein and its amyloid. The enthalpy changes for the
amyloid sample are almost identical to those seen for the
globular protein ubiquitin.
To bridge our hydration measurements with previous
structural studies, we investigated the monomeric wild-
type a-synuclein and 10 different globular proteins using
MD simulations of 101 representative structures of the
a-synuclein ensemble (23). These structures were derived
by performing NMR measurements on spin-labeled
a-synuclein, incorporating the resulting long-range distance
constraints into ensemble MD simulations. In our case, MD
simulations were used to place water molecules around the
101 structures, which were then analyzed for distribution as
a function of distance from the protein surface, as given inMaterials and Methods. In short, we used the solvateShell
function of the sleap program to place water molecules,
calculated their distance from the nearest heavy atom of
the protein, and then determined the number of water mole-
cules within a given distance range.
Using this approach, we found the same qualitative and
quantitative differences between the hydration shells of
ordered and disordered proteins that were reported in earlier
experimental work (35) also observed here by NMR at
25 mg/ml. The hydration shell within 5 A˚ contains exactly
the same number of water molecules/residue around both
ordered and disordered proteins as in the first hydration shell
found by solid-phase NMR (Fig. 6 A). We found earlier in
our measurements that the melting point of the first hydra-
tion shell is lower in globular proteins (see, e.g., Tompa
and co-workers (31,32). We also found with MD simula-
tions that the distance distribution of water molecules
from the protein in a 5-A˚ shell (Fig. 6 B) is significantly
different between the globular domains and a-synuclein
(unpaired t-test, p ¼ 0.0077). This difference means that
the first hydration shell around globular proteins is more
compact (more water molecules can be found near to the
protein), which may also explain our previous finding (35)
related to the melting point of the first hydration shell. We
hypothesized that the dominant protein environment of
water molecules can lower the melting point of the hydra-
tion shell more around globular proteins than around disor-
dered proteins with dominant water environment.DISCUSSION
Previous structural studies on a-synuclein (19,22,23) have
addressed structural details of the largely disordered protein
that are of importance for amyloid formation in PD. In these
studies, it has always been implied that an important
readout of observed structural differences is the level and
heterogeneity of hydration of the protein. Because familial
mutants of a-synuclein, which show subtle differences in
structure from the wild-type protein, are more prone toBiophysical Journal 101(9) 2260–2266
FIGURE 6 Molecular dynamics simulation of the hydration shell on
globular domains and a-synuclein models. (A) Number of water molecules
normalized to the number of residues as a function of hydration shell extent.
The hydration shell was modeled using the sleap module of AmberTools on
10 selected globular domain and 101 a-synuclein structures (see Methods).
The dotted line corresponds to the first hydration shell water number
measured by NMR. (Inset) The first derivates of the curves. (B) Frequency
distribution of the distance of water molecules (oxygen atom) from the
nearest protein heavy atom in the 5-A˚-extent hydration shell.
2264 Hazy et al.aggregation (18,20,24), we expected that these differences
might also be manifested in hydration, which is thus critical
in amyloidogenic propensity of the protein. In this article,
we demonstrate that wide-line NMR combined with DSC
and MD can provide insights about such details of protein
hydration.
We found that the a-synuclein and other proteins studied
have an overall hydration value close or equal to 0.3 g
water/g protein, typical for proteins in general (36). Further-
more, the hydration curves have features characteristic of
intrinsically disordered proteins (Fig. 3). The thermal trends
of the hydration curves for wild-type protein and A53T
mutant are very similar at the lower protein concentration,
25 mg/ml (Fig. 1). It is important to note that we could
detect a small but systematic difference between the A53T
variant and the wild-type protein in the actual amounts of
the mobile water phase, as well as in the lowest temperature
limits where mobile water phases could be detected (Fig. 1).
This clearly suggests a bias for more open structures, with
the potential of binding more water molecules in the case
of the mutant. In principle, this observation agrees with
prior observations that in the wild-type protein there is
a transient a-helical structure (27) and long-range interac-
tions (23), which are partially released by the A53T mu-
tation and thus give way to more extended structuresBiophysical Journal 101(9) 2260–2266(22,27). The compaction that results from the underlying
intramolecular interactions may have a role in keeping
the aggregation-prone NAC region away from unwanted
intermolecular interactions, as suggested recently for intrin-
sically disordered proteins in general (37).We have demon-
strated here that such a structural transition is manifested in
an increased level of hydration.
The similarity of the hydration-versus-temperature curves
for wild-type and A53T mutant a-synuclein at the higher
concentration, 50 mg/ml (Fig. 2), probably signals the
tendency of the protein to undergo amyloid formation,
which brings it to a uniform structural state irrespective of
the initial structural ensemble. The same conclusion was
previously drawn from observations made by a range of
structural techniques (18,19). It is also worthy of note that
these hydration curves resemble that of globular proteins
but retain some characteristics of disordered proteins
(Fig. 2), i.e., their thermal behavior is different from both
the intrinsically disordered and globular proteins. That is,
the amyloid fibrils are surrounded by a lower amount of mo-
bile water phase than monomeric proteins (Figs. 3 and 4)
and exhibit a heterogeneous solvent-accessible surface in
terms of protein-water interactions. This behavior suggests
that even in the highly ordered aggregated/amyloid state
a-synuclein has some residual structural disorder. Such
structural disorder in amyloid has already been demon-
strated by different techniques, such as hydrogen-deuterium
exchange (38), solid-state NMR (39), and site-directed spin-
labeling (40) for a-synuclein, as well as for other proteins
(41,42). This phenomenon is an extension of fuzziness,
i.e., structural disorder of intrinsically disordered proteins
in the bound state (43). The enthalpy changes measured
relative to water also differentiate between the monomeric
protein and the amyloid fibril samples, but do not show
much difference between the amyloid fibril and the globular
protein ubiquitin (Fig. 5). The quantitative relevance of all
these observations is underlined by MD simulations, which
show that the measured behavior corresponds to the first
hydration layer of the structural ensemble of the protein.
Thus, the evolution with temperature of the hydrate layer
of a-synuclein observed using our combination of tech-
niques corresponds to that observed by solution NMR (23).
In this sense, our combination of techniques is appro-
priate to provide qualitative and quantitative information
on water molecules in contact with the protein molecule.
Because the formation of amyloid results from changes in
the fine balance of intermolecular and intramolecular inter-
actions of proteins, both of which critically depend on the
presence, binding, and dynamics of water molecules in the
hydration shell, we suggest that a detailed description of
hydration is a good proxy for addressing the amyloidogenic
character of proteins. Our approach sets a precedent for such
studies, and suggests a potential way to address the delete-
rious molecular events that occur in structural transitions
of a-synuclein in Parkinson’s disease.
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